- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 00:01 | XFRA NEW INSTRUMENTS AVAILABLE ON 13.11.2025 | 104 | Xetra Newsboard | The following instruments on XETRA do have their first trading 13.11.2025 Die folgenden Instrumente in XETRA haben ihren ersten Handelstag 13.11.2025
Aktien
1 US92892B1035 Voyager Technologies... ► Artikel lesen | |
| 27.10. | TempraMed Technologies Ltd: TempraMed to Support Beyond Type 1's Beyond Type Run Team at the 2025 TCS New York City Marathon | 193 | Newsfile | Vancouver, British Columbia--(Newsfile Corp. - October 27, 2025) - TempraMed Technologies Ltd. (CSE: VIVI) ("TempraMed" or the "Company") the innovator behind the VIVI product line of temperature-protective... ► Artikel lesen | |
| 21.10. | Tempramed Technologies Ltd: Tempramed arranges $2.5-million private placement | 2 | Stockwatch | ||
| 21.10. | TempraMed Technologies Ltd: TempraMed Announces Private Placement of up to C$2.5 Million | 144 | Newsfile | Vancouver, British Columbia--(Newsfile Corp. - October 21, 2025) - TempraMed Technologies Ltd. (CSE: VIVI) ("TempraMed" or the "Company") is pleased to announce a non-brokered private placement (the... ► Artikel lesen | |
| TEMPRAMED TECHNOLOGIES Aktie jetzt für 0€ handeln | |||||
| 15.10. | Canadian Securities Exchange (CSE): Canadian Securities Exchange Welcomes Listing of TempraMed Technologies Ltd. | 280 | Newsfile | Toronto, Ontario--(Newsfile Corp. - October 15, 2025) - The Canadian Securities Exchange ("CSE" or "the Exchange") today welcomed the listing of TempraMed Technologies Ltd. ("TempraMed" or the "Company").... ► Artikel lesen | |
| 15.10. | Tempramed Technologies Ltd: Tempramed Technologies begins trading on CSE | 1 | Stockwatch | ||
| 15.10. | TempraMed to Commence Trading on the Canadian Securities Exchange Under Symbol "VIVI", Today, October 15, 2025 | 157 | Newsfile | Vancouver, British Columbia--(Newsfile Corp. - October 15, 2025) - TempraMed Technologies Ltd. (CSE: VIVI) ("TempraMed" or the "Company") is pleased to announce that it has received approval to list... ► Artikel lesen | |
| 14.10. | Tempramed Technologies Ltd: Tempramed Technologies to list on CSE | 1 | Stockwatch | ||
| 14.10. | CSE Bulletin: New Listing - TempraMed Technologies Ltd. (VIVI) | 299 | Newsfile | Toronto, Ontario--(Newsfile Corp. - Le 14 octobre/October 2025) - The common shares of TempraMed Technologies Ltd. have been approved for listing on the CSE. Listing and disclosure documents... ► Artikel lesen | |
| 10.10. | TempraMed Receives Final Receipt for Prospectus and Closes Reverse Takeover Transaction of TempraMed Israel | 280 | Newsfile | Vancouver, British Columbia--(Newsfile Corp. - October 10, 2025) - TempraMed Technologies Ltd. (the "Company") is pleased to announce that the Company has filed and obtained a receipt on September... ► Artikel lesen | |
| 03.09. | TempraMed Closes Oversubscribed C$7.4M Financing and Advances Toward Go Public Listing | 305 | Newsfile | Sammamish, Washington--(Newsfile Corp. - September 3, 2025) - TempraMed Ltd. ("TempraMed" or the "Company"), a medical technology innovator redefining how temperature-sensitive medications are stored... ► Artikel lesen | |
| 07.08. | TempraMed Partners with the Diabetes Education & Camping Association of the USA (DECA), Supporting Safe Insulin Storage for Children at Diabetes Camps Across the United States | 329 | Newsfile | Sammamish, Washington--(Newsfile Corp. - August 7, 2025) - TempraMed Ltd. ("TempraMed" or the "Company"), a medical technology innovator transforming how temperature-sensitive medications are stored... ► Artikel lesen |
12 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| SIEMENS HEALTHINEERS | 43,840 | -2,19 % | JPMORGAN stuft Siemens Healthineers auf 'Overweight' | NEW YORK (dpa-AFX Analyser) - Die US-Bank JPMorgan hat die Einstufung für Siemens Healthineers mit einem Kursziel von 61,30 Euro auf "Overweight" belassen. Es gebe keine Eile beim Kauf der Aktien, schrieb... ► Artikel lesen | |
| LIFESTANCE HEALTH GROUP | 6,440 | 0,00 % | LifeStance Health Group, Inc.: LifeStance Reports Third Quarter 2025 Results | SCOTTSDALE, Ariz., Nov. 06, 2025 (GLOBE NEWSWIRE) -- LifeStance Health Group, Inc. (Nasdaq: LFST), one of the nation's largest providers of outpatient mental healthcare, today announced financial... ► Artikel lesen | |
| FRESENIUS | 49,340 | -0,86 % | BARCLAYS stuft Fresenius SE auf 'Overweight' | LONDON (dpa-AFX Analyser) - Die britische Investmentbank Barclays hat das Kursziel für Fresenius von 51 auf 54 Euro angehoben und die Einstufung auf "Overweight" belassen. Die Bad Homburger stemmten... ► Artikel lesen | |
| AVEANNA HEALTHCARE | 8,800 | -2,11 % | Aveanna Healthcare Holdings, Inc: Aveanna Healthcare Holdings Announces Third Quarter Financial Results and Revised 2025 Outlook | Third Quarter Revenue was $621.9 million, a 22.2% increase over the prior year periodThird Quarter Net income was $14.1 million compared to Net loss of $42.8 million for the prior year periodAdjusted... ► Artikel lesen | |
| FRESENIUS MEDICAL CARE | 41,340 | -0,70 % | BARCLAYS stuft FMC FRESENIUS MEDICAL CARE AG auf 'Equal Weight' | LONDON (dpa-AFX Analyser) - Die britische Investmentbank Barclays hat das Kursziel für FMC von 50,50 auf 51 Euro angehoben, aber die Einstufung auf "Equal Weight" belassen. Die Behandlungszahlen des... ► Artikel lesen | |
| PROGYNY | 24,090 | 0,00 % | Progyny, Inc. Announces Third Quarter 2025 Results | Reports Revenue of $313.3 Million, Reflecting 9.3% GrowthRaises Full Year Guidance to Reflect Continued Strength in Member EngagementSelling Season Yields Over 80 New Clients, 900,000 New Lives, and... ► Artikel lesen | |
| CASTLE BIOSCIENCES | 34,820 | 0,00 % | SciBase and Castle Biosciences expand collaboration and license agreement and enter into loan agreement of SEK 20 million | STOCKHOLM, Nov. 7, 2025 /PRNewswire/ -- SciBase Holding AB ("SciBase") (STO: SCIB), a leading developer of AI-based diagnostic solutions for skin disorders, today announced that SciBase... ► Artikel lesen | |
| GENEDX | 136,29 | 0,00 % | GeneDx to Participate in Upcoming Investor Conferences | GeneDx (Nasdaq: WGS), a leader in delivering improved health outcomes through genomic insights, today announced that company management will participate in upcoming investor conferences:
Stifel... ► Artikel lesen | |
| BRIGHTSPRING HEALTH SERVICES | 33,640 | 0,00 % | S&P Dow Jones Indices: BrightSpring Health Services Set to Join S&P SmallCap 600 | NEW YORK, Oct. 14, 2025 /PRNewswire/ -- BrightSpring Health Services Inc. (NASD: BTSG) will replace Veritex Holdings Inc. (NASD: VBTX) in the S&P SmallCap 600 effective... ► Artikel lesen | |
| ALIGNMENT HEALTHCARE | 16,610 | 0,00 % | Alignment Healthcare Reports Third Quarter 2025 Results, Surpasses High-End of Guidance Across All Key Metrics | Reports Q3 revenue of $993.7 million, up 43.5% year-over-yearBeats high end of third quarter guidance and raises full-year outlook across all key metrics: membership, revenue, adjusted gross profit... ► Artikel lesen | |
| PROCEPT BIOROBOTICS | 30,750 | 0,00 % | PROCEPT BioRobotics Reports Third Quarter 2025 Financial Results and Issues 2026 Revenue Guidance | SAN JOSE, Calif., Nov. 04, 2025 (GLOBE NEWSWIRE) -- PROCEPT BioRobotics® Corporation (Nasdaq: PRCT) (the "Company"), a surgical robotics company focused on advancing patient care by developing transformative... ► Artikel lesen | |
| ECKERT & ZIEGLER | 16,690 | +7,33 % | EQS-News: Eckert & Ziegler SE: Eckert & Ziegler mit erneutem Ergebniswachstum und zweistelligem Umsatzwachstum im Segment Medical | EQS-News: Eckert & Ziegler SE
/ Schlagwort(e): 9-Monatszahlen/Quartalsergebnis
Eckert & Ziegler mit erneutem Ergebniswachstum und zweistelligem Umsatzwachstum im Segment Medical... ► Artikel lesen | |
| GERRESHEIMER | 24,400 | -0,08 % | Vorsicht bei Plug Power und Gerresheimer! Gold Richtung 10.000 USD! Was macht die Formation Metals Aktie? | Experten sehen bei Formation Metals die Chance auf eine Multi-Million-Unzen-Story mit Übernahmefantasie. Zudem entspricht die Cashposition des kanadischen Explorationsunternehmens fast der Marktkapitalisierung.... ► Artikel lesen | |
| PRIVIA HEALTH GROUP | 24,200 | 0,00 % | Privia Health Group, Inc.: Privia Health Reports Third Quarter 2025 Financial Results | Very Strong Third Quarter and Year-to-Date Performance Across the BusinessNet Income +94.1% and Adjusted EBITDA +61.6% compared to 3Q'24Implemented Providers +13.1% and Practice Collections +27.1%... ► Artikel lesen | |
| HEARTFLOW | 35,820 | 0,00 % | Canaccord hebt Kursziel für HeartFlow nach starken Zahlen auf 40 US-Dollar an |
TEMPRAMED TECHNOLOGIES LTD gehört der Branche Gesundheitswesen an. Mit einer aktuellen Kursveränderung von 0,000 (0,00 %) liegt der Kurs bei 0,475 Euro.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und .
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu TEMPRAMED TECHNOLOGIES LTD finden Sie auf Wallstreet Online.